ETON - Eton Pharmaceuticals, Inc. Summary, Stock Quote and News | Benzinga

Market Overview

4.780 0.04 (0.84%)

After Hours 4.85 (%)

Data as of May 24, 2020

Prev. Close 4.74
Price Open 4.8
Volume 74,055
Day's Range 4.52 - 4.81
52 Wk Range 2.5 - 9.07
50 Day Moving Avg. 4.36
PE Ratio 0
Shares Outstanding 20.92M
Market Cap 99.98M

Trade ETON stock for free with recommended broker TD Ameritrade.

Analyst Rating View All Ratings

B. Riley FBR Maintains Buy on Eton Pharmaceuticals, Lowers Price Target to $10 vishwanath@benzinga.comFri, 15 May 2020 07:21:01 -0400
Eton Pharmaceuticals Q1 EPS $(50.000) May Not Compare To $(0.220) Estimate, Sales $99.000K May Not Compare To $1.510M Estimate Benzinga NewsdeskThu, 14 May 2020 16:03:43 -0400
The Daily Biotech Pulse: ASCO Abstracts Create Stock Ripples, Applied DNA's Coronavirus Test Receives EUA, Biopharmx Shareholders Vet Reverse Merger Shanthi RexalineThu, 14 May 2020 08:32:43 -0400
The Week Ahead In Biotech: Virtual Conference Presentations, Clovis PDUFA Date In The Spotlight Shanthi RexalineSun, 10 May 2020 15:40:37 -0400
H.C. Wainwright Reiterates Buy on Eton Pharmaceuticals, Raises Price Target to $26 Benzinga_NewsdeskMon, 30 Mar 2020 07:14:15 -0400
90 Biggest Movers From Friday Lisa LevinMon, 30 Mar 2020 05:10:15 -0400
Mid-Afternoon Market Update: Dow Falls 550 Points; BIO-key Shares Spike Higher Lisa LevinFri, 27 Mar 2020 14:35:52 -0400
55 Stocks Moving In Friday's Mid-Day Session Lisa LevinFri, 27 Mar 2020 12:54:15 -0400
Mid-Day Market Update: Crude Oil Down Over 5%; SmileDirectClub Shares Jump Lisa LevinFri, 27 Mar 2020 12:41:31 -0400
Eton Pharma Reports Purchase Of US Marketing rights To Pediatric Orphan Drug Alkindi Sprinkle For $3.5M In Cash, ~379.5K Shares Of Co. Stock Benzinga NewsdeskFri, 27 Mar 2020 07:01:55 -0400
{{ story.title }} {{ story.author }}{{ story.created }}

Show more Loading articles...

Eton Pharmaceuticals Announces First Quarter 2020 Financial Results Globe NewswireMay 14, 2020
Eton Pharmaceuticals Confirms First-to-File Patent Challenge on Elcys (Cysteine Hydrochloride Injection) Globe NewswireMay 07, 2020
Eton Pharmaceuticals to Report First Quarter Financial Results on Thursday, May 14, 2020 Globe NewswireMay 06, 2020
Eton Pharmaceuticals Announces Appointment of Paul Stickler as Senior Vice President of Sales and Marketing Globe NewswireMay 04, 2020
Eton Pharmaceuticals Announces Acquisition of U.S Marketing Rights to Pediatric Orphan Drug Alkindi® Sprinkle Globe NewswireMar 27, 2020
Eton Pharmaceuticals Reports Positive Study Results for ET-101 (Topiramate Oral Solution) Globe NewswireMar 17, 2020
Eton Pharmaceuticals Announces Fourth Quarter and Full Year 2019 Financial Results Globe NewswireMar 05, 2020
Eton Pharmaceuticals, Inc. to Host Earnings Call ACCESSWIREMar 05, 2020
Eton Pharmaceuticals to Report Fourth Quarter and Full Year 2019 Financial Results on Thursday, March 5, 2020 Globe NewswireFeb 27, 2020
Eton Pharmaceuticals Provides Update on ET-105 Program Globe NewswireFeb 19, 2020
{{ story.title }} {{ story.author }}{{ story.created }}

Show more Loading articles...

Opaleye Management Inc. Buys Protara Therapeutics Inc, Eton Pharmaceuticals Inc, Kala ... GuruFocus2 days ago
Eton Pharmaceuticals, Inc. (ETON) Expected to Beat Earnings Estimates: Should You Buy? ZacksApr 28, 2020
Company News for Mar 30, 2020 ZacksMar 30, 2020
Eton Pharmaceuticals Announces Acquisition of U. ... GuruFocusMar 27, 2020
Eton Pharmaceuticals, Inc. (ETON) Upgraded to Buy: Here's What You Should Know ZacksMar 26, 2020
Eton Pharmaceuticals, Inc. (ETON) Reports Q4 Loss, Misses Revenue Estimates ZacksMar 05, 2020
Eton Pharmaceuticals to Report Fourth Quarter and Full Year —…–9 Financial Results on ... GuruFocusFeb 27, 2020
Teladoc (TDOC) to Post Q4 Earnings: What's in the Cards? ZacksFeb 24, 2020
Eton Pharmaceuticals Provides Update on ET-–…5 Program GuruFocusFeb 19, 2020
Eton Pharmaceuticals and Xellia Pharmaceuticals Announce Biorphen® (phenylephrine HCl) ... GuruFocusJan 21, 2020
{{ story.title }} {{ story.author }}{{ story.created }}

Show more Loading articles...

Earnings View Earnings

Q1 2020	EST	Actual	Surprise
EPS:	-0.220	-0.500	-0.2800
Rev:	1.51M	99.00K	-1.41M

Q2 2020	EST	Actual	Surprise
EPS:	Expected 2020-08-04
Rev:	Expected 2020-08-04

Company Profile

Read More

Visit company website

Start Investing

The Best Online Stock Trading Brokers

Best Free Stock Trading Brokers

Best Forex Brokers

Best Futures Brokers

How to Invest in Real Estate

Best Day Trading Courses

Brokerage Center

Compare All Online Brokerages